https://condrug.com/why-modern-pharmacovigilance-matters-in-a-data-driven-healthcare-world/2025-11-11T21:27:46+00:00https://condrug.com/top-10-pharmacovigilance-trends-in-2025-how-ai-is-transforming-drug-safety/2025-11-26T02:14:55+00:00https://condrug.com/how-ai-is-transforming-pharmacovigilance-the-future-of-drug-safety-monitoring/2025-11-26T08:19:31+00:00https://condrug.com/how-ai-is-transforming-pharmacovigilance-drug-safety-in-the-era-of-big-data/2025-11-26T14:23:39+00:00https://condrug.com/zavegepant-for-migraine-how-this-intranasal-cgrp-antagonist-is-changing-acute-treatment/2025-11-26T14:57:14+00:00https://condrug.com/breakthrough-glp%e2%80%911-gip-dual-agonist-tirzepatide-the-next-generation-in-type-2-diabetes-and-obesity-treatment/2025-11-26T14:58:59+00:00https://condrug.com/atogepant-for-migraine-prevention-how-this-next-gen-cgrp-antagonist-is-changing-care/2025-11-26T15:21:02+00:00https://condrug.com/ai-designed-protein-peptide-therapeutics-beyond-antibodies-and-insulin/2025-11-26T15:32:12+00:00https://condrug.com/what-are-protacs-how-targeted-protein-degraders-are-redefining-small-molecule-drugs/2025-11-26T15:32:35+00:00https://condrug.com/what-are-ai-designed-small-molecule-drugs-how-ai-transforms-drug-discovery/2025-11-26T15:35:27+00:00https://condrug.com/how-ai-is-transforming-pharmacovigilance-signal-detection-without-replacing-human-experts/2025-11-26T19:54:04+00:00https://condrug.com/ai-driven-pharmacovigilance-how-ai-is-transforming-drug-safety-monitoring/2025-11-26T20:00:29+00:00https://condrug.com/what-are-glp%e2%80%911-gip-dual-agonists-dual-incretin-peptide-therapy-for-obesity-type-2-diabetes/2025-11-26T20:28:05+00:00https://condrug.com/what-is-crispr-based-gene-editing-therapy-mechanism-benefits-applications/2025-11-26T21:02:45+00:00https://condrug.com/ai-designed-small-molecule-antibiotics-how-machine-learning-is-reinventing-the-war-against-superbugs/2025-11-26T21:58:12+00:00https://condrug.com/revolutionizing-obesity-treatment-how-the-dual-gip-glp%e2%80%911-peptide-tirzepatide-is-changing-the-future-of-metabolic-medicine/2025-11-27T01:19:37+00:00https://condrug.com/ai-driven-pharmacovigilance-how-machine-learning-is-transforming-drug-safety/2025-11-27T00:12:29+00:00https://condrug.com/retatrutide-vs-tirzepatide-how-triple-agonists-are-redefining-obesity-treatment/2025-11-27T03:08:35+00:00https://condrug.com/from-serendipity-to-algorithms-how-generative-ai-is-transforming-small-molecule-drug-discovery/2025-11-27T04:21:00+00:00https://condrug.com/ai-powered-pharmacovigilance-how-machine-learning-is-transforming-drug-safety-monitoring/2025-11-27T04:28:36+00:00https://condrug.com/peptide-based-biologics-in-autoimmune-disease-how-vedolizumab-is-redefining-ibd-therapy/2025-11-27T05:33:33+00:00https://condrug.com/ai-in-pharmacovigilance-how-artificial-intelligence-is-transforming-drug-safety-monitoring/2025-11-27T08:42:21+00:00https://condrug.com/atogepant-for-migraine-prevention-how-it-works-benefits-clinical-trial-data/2025-11-27T16:54:03+00:00https://condrug.com/ai-in-pharmacovigilance-transforming-drug-safety-with-real%e2%80%91time-intelligence/2025-11-27T16:55:02+00:00https://condrug.com/why-tirzepatide-is-revolutionizing-obesity-treatment-dual-gip-glp%e2%80%911-peptide-explained/2025-11-27T16:56:08+00:00https://condrug.com/ai%e2%80%91designed-small-molecules-the-missing-link-in-precision-medicine/2025-11-27T16:59:05+00:00https://condrug.com/how-ai-is-transforming-pharmacovigilance-into-real%e2%80%91time-drug-safety-intelligence/2025-11-27T17:10:17+00:00https://condrug.com/oral-small-molecule-glp%e2%80%911-agonists-next%e2%80%91gen-pills-for-type-2-diabetes-and-obesity/2025-11-27T17:11:09+00:00https://condrug.com/why-tirzepatide-is-a-breakthrough-peptide-for-type-2-diabetes-and-obesity-treatment/2025-11-27T19:43:23+00:00https://condrug.com/ai-driven-pharmacovigilance-how-machine-learning-is-transforming-drug-safety-2/2025-11-27T21:22:27+00:00https://condrug.com/zavegepant-for-migraine-how-this-intranasal-cgrp-antagonist-is-changing-treatment/2025-11-27T21:28:10+00:00https://condrug.com/what-are-protacs-how-protein-degraders-are-transforming-cancer-therapy/2025-11-27T23:33:47+00:00https://condrug.com/how-ai-is-transforming-pharmacovigilance-and-drug-safety-monitoring/2025-11-28T01:37:38+00:00https://condrug.com/what-makes-tirzepatide-different-dual-gip-glp%e2%80%911-peptide-for-obesity-type-2-diabetes/2025-11-28T02:43:39+00:00https://condrug.com/deucravacitinib-tyk2-inhibitor-mechanism-of-action-clinical-trials-psoriasis-benefits/2025-11-28T03:37:44+00:00https://condrug.com/ai-enhanced-pharmacovigilance-how-machine-learning-is-transforming-drug-safety/2025-11-28T05:53:13+00:00https://condrug.com/orforglipron-oral-glp%e2%80%911-receptor-agonist-for-weight-loss-type-2-diabetes/2025-11-28T09:45:35+00:00https://condrug.com/erenumab-for-migraine-prevention-how-cgrp-blockade-is-changing-treatment/2025-11-28T09:46:30+00:00https://condrug.com/ai-driven-pharmacovigilance-how-machine-learning-is-transforming-drug-safety-in-real-time/2025-11-28T10:06:18+00:00https://condrug.com/generative-ai-for-small-molecule-drug-discovery-from-serendipity-to-algorithms/2025-11-28T12:17:39+00:00https://condrug.com/ai-driven-pharmacovigilance-transforming-drug-safety-with-real-time-signal-detection/2025-11-28T14:17:31+00:00https://condrug.com/zuranolone-for-depression-mechanism-rapid-onset-and-clinical-data-explained/2025-11-28T15:51:03+00:00https://condrug.com/why-tirzepatide-is-redefining-peptide-therapy-for-type-2-diabetes/2025-11-28T16:52:43+00:00https://condrug.com/how-ai-is-transforming-pharmacovigilance-real-world-drug-safety-with-advanced-analytics/2025-11-28T18:29:44+00:00https://condrug.com/ai-designed-small-molecule-drugs-how-generative-models-are-transforming-discovery/2025-11-28T18:41:11+00:00https://condrug.com/casgevy-gene-therapy-how-this-crispr-breakthrough-treats-sickle-cell-disease-and-%ce%b2-thalassemia/2025-11-28T21:57:31+00:00https://condrug.com/how-ai-is-transforming-pharmacovigilance-and-drug-safety-workflows/2025-11-28T22:43:21+00:00https://condrug.com/from-undruggable-to-drugged-krasg12c-inhibitors-and-the-future-of-kras-targeted-cancer-therapy/2025-11-29T01:04:33+00:00https://condrug.com/ai-powered-pharmacovigilance-how-intelligent-safety-systems-transform-drug-risk-detection/2025-11-29T02:54:05+00:00https://condrug.com/zavegepant-nasal-spray-for-acute-migraine-how-it-works-benefits-and-clinical-evidence/2025-11-29T04:05:29+00:00https://condrug.com/what-makes-tirzepatide-different-dual-gip-glp%e2%80%911-mechanism-benefits-clinical-outcomes/2025-11-29T06:58:58+00:00https://condrug.com/ai-first-pharmacovigilance-how-machine-learning-is-redefining-drug-safety/2025-11-29T07:07:42+00:00https://condrug.com/why-kras-was-long-considered-undruggable-and-how-new-kras-inhibitors-are-changing-cancer-therapy/2025-11-29T07:26:20+00:00https://condrug.com/retatrutide-for-weight-loss-how-this-triple-agonist-works-for-obesity-metabolic-health/2025-11-29T10:13:35+00:00https://condrug.com/ai-first-signal-management-the-next-frontier-in-drug-safety-pharmacovigilance/2025-11-29T11:18:32+00:00https://condrug.com/how-ai-is-transforming-small-molecule-drug-discovery-and-modern-pharmacology/2025-11-29T13:54:54+00:00https://condrug.com/what-makes-tirzepatide-different-dual-gip-glp%e2%80%911-twincretin-for-type-2-diabetes-weight-loss/2025-11-29T13:59:29+00:00https://condrug.com/what-is-ai-driven-pharmacovigilance-how-machine-learning-is-transforming-drug-safety/2025-11-29T15:34:39+00:00https://condrug.com/deucravacitinib-explained-tyk2-inhibitor-mechanism-uses-and-safety-vs-jak-inhibitors/2025-11-29T16:20:34+00:00https://condrug.com/how-ai-is-transforming-pharmacovigilance-and-drug-safety-monitoring-2/2025-11-29T19:45:39+00:00https://condrug.com/from-injectable-peptides-to-oral-pills-the-new-era-of-small%e2%80%91molecule-glp%e2%80%911-agonists/2025-11-29T20:18:18+00:00https://condrug.com/tirzepatide-peptide-drug-dual-gip-glp%e2%80%911-agonist-redefining-obesity-and-metabolic-care/2025-11-29T21:02:44+00:00https://condrug.com/retatrutide-explained-triple%e2%80%91agonist-weight-loss-drug-results-how-it-works/2025-11-29T22:27:51+00:00https://condrug.com/ai-driven-pharmacovigilance-how-machine-learning-is-transforming-drug-safety-monitoring/2025-11-29T23:58:02+00:00https://condrug.com/from-inhibition-to-elimination-how-protac-small-molecule-drugs-are-transforming-oncology/2025-11-30T02:37:48+00:00https://condrug.com/ai-driven-pharmacovigilance-how-machine-learning-is-transforming-drug-safety-monitoring-2/2025-11-30T04:07:59+00:00https://condrug.com/tirzepatide-explained-dual-gip-glp%e2%80%911-peptide-therapy-transforming-obesity-treatment/2025-11-30T04:11:35+00:00https://condrug.com/what-is-tirzepatide-dual-incretin-weight-loss-diabetes-treatment-explained/2025-11-30T04:38:44+00:00https://condrug.com/ai-powered-pharmacovigilance-why-ai-first-drug-safety-is-no-longer-optional/2025-11-30T08:18:36+00:00https://condrug.com/how-generative-ai-is-transforming-small-molecule-drug-discovery/2025-11-30T09:02:33+00:00https://condrug.com/what-is-bempedoic-acid-mechanism-of-action-benefits-clear-outcomes-data/2025-11-30T10:45:33+00:00https://condrug.com/erenumab-aimovig-vs-traditional-migraine-drugs-how-cgrp-inhibitors-change-prevention/2025-11-30T11:12:30+00:00https://condrug.com/ai-driven-pharmacovigilance-how-machine-learning-is-transforming-drug-safety-3/2025-11-30T12:31:20+00:00https://condrug.com/oral-small-molecule-glp%e2%80%911-agonists-from-weekly-injections-to-daily-pills/2025-11-30T15:23:09+00:00https://condrug.com/ai-driven-pharmacovigilance-from-passive-reporting-to-real-time-drug-safety-intelligence/2025-11-30T16:41:24+00:00https://condrug.com/deucravacitinib-tyk2-inhibitor-mechanism-of-action-benefits-safety-in-autoimmune-disease/2025-11-30T16:52:11+00:00https://condrug.com/what-is-tirzepatide-dual-gip-glp%e2%80%911-twincretin-for-type-2-diabetes-and-weight-loss/2025-11-30T18:17:35+00:00https://condrug.com/ai-powered-pharmacovigilance-managing-polypharmacy-risk-in-real-time/2025-11-30T20:50:18+00:00https://condrug.com/how-ai-is-transforming-covalent-small-molecule-drug-design/2025-11-30T21:45:24+00:00https://condrug.com/what-is-atogepant-oral-cgrp-antagonist-for-migraine-prevention-explained/2025-11-30T22:58:42+00:00https://condrug.com/ai-powered-pharmacovigilance-real-time-drug-safety-twins-next-gen-risk-prediction/2025-12-01T01:02:25+00:00https://condrug.com/what-makes-tirzepatide-different-dual-gip-glp%e2%80%911-peptide-for-weight-loss-diabetes/2025-12-01T01:23:26+00:00https://condrug.com/what-are-protacs-how-proteolysis-targeting-chimeras-are-transforming-oncology/2025-12-01T04:09:01+00:00https://condrug.com/what-is-tirzepatide-dual-gip-glp%e2%80%911-weight-loss-diabetes-breakthrough-explained/2025-12-01T05:04:06+00:00https://condrug.com/ai-powered-pharmacovigilance-how-machine-learning-transforms-drug-safety/2025-12-01T05:17:46+00:00https://condrug.com/tirzepatide-vs-glp%e2%80%911-how-dual-incretin-agonists-transform-diabetes-and-obesity-treatment/2025-12-01T08:26:08+00:00https://condrug.com/ai-powered-pharmacovigilance-building-digital-safety-twins-for-smarter-drug-safety/2025-12-01T09:30:49+00:00https://condrug.com/what-makes-next-generation-protacs-different-molecular-assassins-in-drug-discovery/2025-12-01T10:33:17+00:00https://condrug.com/mij821-next%e2%80%91generation-nmda-modulator-redefining-rapid%e2%80%91acting-antidepressants/2025-12-01T11:15:14+00:00https://condrug.com/ai-driven-pharmacovigilance-2-0-why-traditional-drug-safety-cant-keep-up/2025-12-01T13:41:53+00:00https://condrug.com/tirzepatide-twincretin-peptide-dual-gip-glp%e2%80%911-agonist-engineering-weight-loss-results/2025-12-01T15:26:54+00:00https://condrug.com/ai-designed-small-molecule-drugs-how-machine-learning-is-transforming-drug-discovery/2025-12-01T16:57:12+00:00https://condrug.com/ai-driven-digital-safety-twins-in-pharmacovigilance-transforming-drug-safety-monitoring/2025-12-01T17:50:46+00:00https://condrug.com/ai-powered-pharmacovigilance-building-an-ai-ready-drug-safety-system/2025-12-01T22:00:43+00:00https://condrug.com/from-lab-tool-to-protein-drug-how-cas9-became-a-programmable-crispr-therapeutic/2025-12-01T22:27:29+00:00https://condrug.com/protac-small-molecules-in-oncology-targeted-protein-degradation-for-undruggable-cancer-targets/2025-12-01T23:15:49+00:00https://condrug.com/what-is-deucravacitinib-mechanism-benefits-role-in-plaque-psoriasis/2025-12-01T23:32:41+00:00https://condrug.com/from-ai-pilots-to-scalable-pharmacovigilance-building-ai-ready-drug-safety-workflows/2025-12-02T02:17:33+00:00https://condrug.com/what-is-tirzepatide-dual-gip-glp%e2%80%911-agonist-mechanism-benefits-weight-loss-results/2025-12-02T05:34:09+00:00https://condrug.com/zavegepant-nasal-spray-for-migraine-how-it-works-benefits-clinical-data/2025-12-02T05:39:16+00:00https://condrug.com/ai-designed-small-molecule-drugs-how-machine-learning-is-rewiring-drug-discovery/2025-12-02T05:41:52+00:00https://condrug.com/why-ai-driven-pharmacovigilance-is-now-essential-for-modern-drug-safety/2025-12-02T06:32:33+00:00https://condrug.com/mrtx1133-and-kras-g12d-a-new-era-in-targeted-oncology/2025-12-02T11:45:51+00:00https://condrug.com/why-targeted-protein-degraders-and-protacs-are-redefining-small-molecule-drugs/2025-12-02T12:02:49+00:00https://condrug.com/what-is-tirzepatide-dual-gip-glp%e2%80%911-mechanism-weight-loss-results-clinical-data/2025-12-02T12:34:32+00:00https://condrug.com/ai-in-pharmacovigilance-how-ai%e2%80%91driven-drug-safety-is-transforming-pharmacovigilance/2025-12-02T14:57:30+00:00https://condrug.com/zavegepant-nasal-spray-for-acute-migraine-how-it-works-and-why-its-different/2025-12-02T17:53:07+00:00https://condrug.com/ai-designed-small-molecule-drugs-how-generative-models-are-reinventing-drug-discovery/2025-12-02T18:23:10+00:00https://condrug.com/from-manual-case-review-to-ai%e2%80%91first-pharmacovigilance-3-0-llms-safety-automation/2025-12-02T19:10:28+00:00https://condrug.com/what-are-glp%e2%80%911-gip-dual-agonists-how-tirzepatide-works-for-weight-loss-type-2-diabetes/2025-12-02T19:37:24+00:00https://condrug.com/ai-driven-pharmacovigilance-how-machine-learning-is-transforming-drug-safety-monitoring-3/2025-12-02T23:20:41+00:00https://condrug.com/what-is-halicin-ai-discovered-antibiotic-and-its-role-in-fighting-resistance/2025-12-02T23:58:26+00:00https://condrug.com/next%e2%80%91generation-protacs-how-molecular-hitmen-are-redefining-targeted-protein-degradation/2025-12-03T00:44:12+00:00https://condrug.com/from-single-to-dual-incretin-therapy-how-tirzepatide-is-transforming-type-2-diabetes-treatment/2025-12-03T02:43:37+00:00https://condrug.com/how-ai-is-transforming-pharmacovigilance-from-manual-review-to-real-time-drug-safety/2025-12-03T03:37:16+00:00https://condrug.com/deucravacitinib-for-psoriasis-how-this-first-in-class-tyk2-inhibitor-works/2025-12-03T06:05:44+00:00https://condrug.com/why-small-molecule-antivirals-are-back-in-the-spotlight-next-generation-antiviral-drugs/2025-12-03T07:08:41+00:00https://condrug.com/ai-powered-pharmacovigilance-in-2025-how-machine-learning-is-transforming-drug-safety/2025-12-03T07:48:23+00:00https://condrug.com/what-is-tirzepatide-dual-gip-glp%e2%80%911-agonist-for-type-2-diabetes-obesity-explained/2025-12-03T09:48:51+00:00https://condrug.com/ai-powered-pharmacovigilance-intelligent-drug-safety-monitoring-modern-risk-management/2025-12-03T12:02:36+00:00https://condrug.com/next-generation-crispr-drug-candidates-from-genome-editing-tool-to-real-therapeutics/2025-12-03T12:14:04+00:00https://condrug.com/what-are-ai-designed-small-molecule-drugs-how-ai-is-transforming-oral-drug-discovery/2025-12-03T13:28:53+00:00https://condrug.com/how-ai-is-transforming-pharmacovigilance-and-drug-safety-in-2025/2025-12-03T16:15:14+00:00https://condrug.com/why-tirzepatide-is-transforming-metabolic-medicine-dual-gip-glp%e2%80%911-agonist-explained/2025-12-03T16:50:39+00:00https://condrug.com/what-is-tirzepatide-dual-gip-glp%e2%80%911-agonist-for-type-2-diabetes-and-weight-loss/2025-12-03T18:23:28+00:00https://condrug.com/why-kras-was-long-considered-undruggable-and-how-g12c-inhibitors-changed-cancer-therapy/2025-12-03T19:52:20+00:00https://condrug.com/ai-powered-pharmacovigilance-real-time-drug-safety-with-machine-learning-nlp/2025-12-03T20:27:19+00:00https://condrug.com/tirzepatide-dual-incretin-peptide-redefining-type-2-diabetes-and-obesity-treatment/2025-12-03T23:52:34+00:00https://condrug.com/ntrx-07-and-alzheimers-disease-a-new-approach-to-microglial-modulation/2025-12-04T00:33:41+00:00https://condrug.com/how-ai-is-transforming-pharmacovigilance-and-drug-safety-in-2025-2/2025-12-04T00:38:11+00:00https://condrug.com/what-is-targeted-protein-degradation-how-protacs-and-molecular-glues-are-redefining-small-molecule-drugs/2025-12-04T02:12:54+00:00https://condrug.com/ai-driven-pharmacovigilance-transforming-drug-safety-with-intelligent-risk-management/2025-12-04T04:50:41+00:00https://condrug.com/lepuledstat-for-multiple-sclerosis-next-generation-brain-penetrant-dhodh-inhibitor/2025-12-04T06:43:35+00:00https://condrug.com/trastuzumab-emtansine-t-dm1-next-generation-her2-targeted-biologic-and-adc-therapy/2025-12-04T06:53:40+00:00https://condrug.com/why-oral-glp%e2%80%911-small-molecules-could-be-the-next-big-metabolic-breakthrough/2025-12-04T08:35:38+00:00https://condrug.com/ai-driven-pharmacovigilance-how-artificial-intelligence-is-transforming-drug-safety/2025-12-04T09:03:25+00:00https://condrug.com/neo-201-antibody-next-generation-neoepitope-targeting-cancer-immunotherapy/2025-12-04T12:52:33+00:00https://condrug.com/what-is-ai-driven-pharmacovigilance-how-ai-transforms-drug-safety-signal-detection/2025-12-04T13:18:06+00:00https://condrug.com/what-is-tirzepatide-dual-gip-glp%e2%80%911-weight-loss-diabetes-breakthrough-explained-2/2025-12-04T13:57:30+00:00https://condrug.com/the-new-metabolic-hack-mitochondrial-uncouplers-that-burn-calories-as-heat-not-fat/2025-12-04T14:55:38+00:00https://condrug.com/how-ai-is-transforming-pharmacovigilance-intelligent-drug-safety-in-the-new-data-driven-era/2025-12-04T17:33:32+00:00https://condrug.com/what-is-aficamten-next%e2%80%91generation-cardiac-myosin-inhibitor-for-hypertrophic-cardiomyopathy/2025-12-04T19:02:36+00:00https://condrug.com/what-is-tirzepatide-dual-incretin-breakthrough-for-type-2-diabetes-and-weight-loss/2025-12-04T21:02:32+00:00https://condrug.com/oral-small-molecule-glp%e2%80%911-agonists-from-weekly-injections-to-daily-pills-2/2025-12-04T21:15:46+00:00https://condrug.com/ai-in-pharmacovigilance-intelligent-automation-signal-detection-for-drug-safety/2025-12-04T21:46:54+00:00https://condrug.com/retatrutide-how-this-triple-agonist-obesity-drug-candidate-redefines-medical-weight-loss/2025-12-05T01:12:04+00:00https://condrug.com/ai-in-pharmacovigilance-how-artificial-intelligence-is-transforming-drug-safety/2025-12-05T02:01:46+00:00https://condrug.com/molecular-glues-in-drug-discovery-from-protein-inhibition-to-targeted-degradation/2025-12-05T03:38:00+00:00https://condrug.com/tirzepatide-explained-dual-gip-glp%e2%80%911-peptide-engineering-mechanism-clinical-impact/2025-12-05T04:03:13+00:00https://condrug.com/ai-in-pharmacovigilance-intelligent-signal-detection-modern-drug-safety-monitoring/2025-12-05T06:19:06+00:00https://condrug.com/what-is-retatrutide-triple-agonist-weight-loss-drug-explained-glp%e2%80%911-gip-glucagon/2025-12-05T07:16:43+00:00https://condrug.com/protacs-and-targeted-protein-degraders-redefining-the-future-of-small-molecule-drugs/2025-12-05T10:03:57+00:00https://condrug.com/ai-driven-pharmacovigilance-how-artificial-intelligence-is-transforming-drug-safety-2/2025-12-05T10:31:43+00:00https://condrug.com/what-is-semaglutide-mechanism-benefits-why-its-so-popular/2025-12-05T11:07:52+00:00https://condrug.com/what-is-crn04894-next-generation-crf1-antagonist-targeting-chronic-stress-biology/2025-12-05T13:27:35+00:00https://condrug.com/ai-driven-pharmacovigilance-how-intelligent-safety-systems-transform-drug-risk-management/2025-12-05T14:42:27+00:00https://condrug.com/what-are-protacs-how-protein-degraders-are-transforming-drug-discovery/2025-12-05T16:28:31+00:00https://condrug.com/what-is-tirzepatide-how-this-dual-incretin-drug-is-redefining-type-2-diabetes-treatment/2025-12-05T18:07:39+00:00https://condrug.com/ai-driven-pharmacovigilance-how-intelligent-drug-safety-surveillance-works/2025-12-05T18:58:46+00:00https://condrug.com/casgevy-gene-therapy-for-sickle-cell-disease-how-crispr-cas9-is-changing-treatment/2025-12-05T19:32:36+00:00https://condrug.com/from-undruggable-to-unstoppable-how-next%e2%80%91generation-kras-inhibitors-are-transforming-cancer-therapy/2025-12-05T22:54:10+00:00https://condrug.com/ai-in-pharmacovigilance-how-machine-learning-is-transforming-drug-safety-monitoring/2025-12-05T23:16:51+00:00https://condrug.com/tirzepatide-why-this-dual-gip-glp%e2%80%911-agonist-is-a-game%e2%80%91changer-for-obesity-and-type-2-diabetes/2025-12-06T01:12:31+00:00https://condrug.com/cenobamate-for-focal-seizures-how-this-next%e2%80%91generation-epilepsy-drug-works/2025-12-06T01:43:48+00:00https://condrug.com/ai-driven-pharmacovigilance-transforming-drug-safety-with-real-world-data-automation/2025-12-06T03:32:33+00:00https://condrug.com/molecular-glues-in-small-molecule-drug-discovery-mechanism-design-therapeutic-potential/2025-12-06T05:16:02+00:00https://condrug.com/how-ai-is-transforming-pharmacovigilance-and-drug-safety-monitoring-3/2025-12-06T07:48:57+00:00https://condrug.com/lerodalcibep-next-generation-pcsk9-inhibitor-for-powerful-ldl-c-lowering/2025-12-06T08:09:55+00:00https://condrug.com/tirzepatide-mechanism-of-action-dual-incretin-peptide-therapy-for-type-2-diabetes/2025-12-06T08:13:27+00:00https://condrug.com/ai-driven-small-molecule-discovery-from-serendipity-to-systematic-drug-design/2025-12-06T11:35:49+00:00https://condrug.com/ai-in-pharmacovigilance-how-machine-learning-is-transforming-drug-safety-monitoring-2/2025-12-06T12:03:36+00:00https://condrug.com/what-is-tirzepatide-dual-incretin-weight-loss-diabetes-treatment-explained-2/2025-12-06T14:15:50+00:00https://condrug.com/tirzepatide-explained-how-dual-glp%e2%80%911-gip-agonism-is-redefining-obesity-treatment/2025-12-06T15:17:13+00:00https://condrug.com/ai-in-pharmacovigilance-how-intelligent-drug-safety-systems-are-transforming-pharmacovigilance/2025-12-06T16:17:30+00:00https://condrug.com/how-ai-is-transforming-oral-small-molecule-drug-design-from-serendipity-to-algorithms/2025-12-06T17:56:36+00:00https://condrug.com/xanomeline-trospium-mechanism-muscarinic-pathway-and-clinical-trial-results/2025-12-06T20:22:30+00:00https://condrug.com/ai-powered-pharmacovigilance-how-ai-is-transforming-drug-safety-monitoring/2025-12-06T20:28:29+00:00https://condrug.com/tirzepatide-for-obesity-dual-incretin-twincretin-therapy-redefining-weight-loss/2025-12-06T22:18:23+00:00https://condrug.com/what-are-protacs-how-small-molecule-protein-degraders-are-redefining-drug-discovery/2025-12-07T00:17:36+00:00https://condrug.com/what-is-ai-driven-pharmacovigilance-how-ai-is-transforming-drug-safety/2025-12-07T00:40:35+00:00https://condrug.com/deucravacitinib-for-plaque-psoriasis-tyk2-inhibitor-mechanism-efficacy-safety/2025-12-07T02:33:46+00:00https://condrug.com/ai-driven-pharmacovigilance-how-ai-is-transforming-drug-safety-monitoring-2/2025-12-07T04:54:37+00:00https://condrug.com/tirzepatide-dual-gip-glp%e2%80%911-peptide-redefining-type-2-diabetes-obesity-treatment/2025-12-07T05:23:13+00:00https://condrug.com/quantum-ready-small-molecules-ai-designed-oncology-drugs-for-the-next-era-of-precision-cancer-therapy/2025-12-07T06:39:30+00:00https://condrug.com/deucravacitinib-a-next%e2%80%91generation-oral-tyk2-inhibitor-transforming-plaque-psoriasis-treatment/2025-12-07T08:40:34+00:00https://condrug.com/ai-in-pharmacovigilance-transforming-drug-safety-with-predictive-analytics/2025-12-07T09:07:16+00:00https://condrug.com/what-are-targeted-protein-degraders-tpds-protac-mechanism-benefits-clinical-progress/2025-12-07T13:02:38+00:00https://condrug.com/ai-powered-pharmacovigilance-how-machine-learning-is-transforming-drug-safety/2025-12-07T13:22:46+00:00https://condrug.com/ai-designed-antivirals-how-nirmatrelvir%e2%80%91x-targets-coronavirus-3cl-protease/2025-12-07T14:47:46+00:00https://condrug.com/ai-in-pharmacovigilance-how-real-time-drug-safety-monitoring-is-transforming-risk-management/2025-12-07T17:33:25+00:00https://condrug.com/tirzepatide-explained-dual-gip-glp%e2%80%911-agonist-redefining-type-2-diabetes-treatment/2025-12-07T19:30:30+00:00https://condrug.com/what-are-ai-designed-small-molecule-drugs-how-ai-is-transforming-drug-discovery/2025-12-07T19:31:04+00:00https://condrug.com/what-is-tirzepatide-dual-gip-glp%e2%80%911-agonist-for-type-2-diabetes-and-weight-loss-2/2025-12-07T20:54:56+00:00https://condrug.com/ai-in-pharmacovigilance-transforming-drug-safety-with-continuous-intelligence/2025-12-07T21:47:37+00:00https://condrug.com/ai-designed-small-molecule-drugs-how-machine-learning-is-transforming-drug-discovery-2/2025-12-08T01:53:42+00:00https://condrug.com/what-is-semaglutide-how-this-glp%e2%80%911-peptide-works-for-weight-loss-and-metabolic-health/2025-12-08T02:30:39+00:00https://condrug.com/novelmab-in-oncology-how-this-next%e2%80%91generation-bispecific-antibody-targets-pd%e2%80%911-and-solid-tumors/2025-12-08T03:00:29+00:00https://condrug.com/ai-in-pharmacovigilance-how-machine-learning-is-transforming-drug-safety-monitoring-3/2025-12-08T06:19:11+00:00https://condrug.com/molecular-glue-degraders-in-oncology-turning-undruggable-cancer-targets-into-therapies/2025-12-08T08:17:39+00:00https://condrug.com/mirdametinib-and-depression-how-mek-inhibition-could-transform-treatment-resistant-mood-disorders/2025-12-08T09:08:40+00:00https://condrug.com/tirzepatide-for-type-2-diabetes-dual-incretin-twincretin-therapy-benefits-weight-loss/2025-12-08T09:32:13+00:00https://condrug.com/ai-in-pharmacovigilance-how-artificial-intelligence-is-transforming-drug-safety-2/2025-12-08T10:32:59+00:00https://condrug.com/intelligent-signal-detection-in-pharmacovigilance-how-ai-is-transforming-drug-safety/2025-12-08T14:43:46+00:00https://condrug.com/zuranolone-fast-acting-oral-antidepressant-for-mdd-and-postpartum-depression/2025-12-08T15:17:47+00:00https://condrug.com/tirzepatide-dual-gip-glp%e2%80%911-twincretin-redefining-peptide-therapies-for-type-2-diabetes-and-obesity/2025-12-08T16:32:37+00:00https://condrug.com/ai-in-pharmacovigilance-transforming-drug-safety-monitoring-and-signal-detection/2025-12-08T18:58:56+00:00https://condrug.com/marituglutide-vs-semaglutide-dual-incretin-agonist-for-weight-loss-diabetes/2025-12-11T12:55:51+00:00https://condrug.com/ai-driven-pharmacovigilance-how-intelligent-safety-systems-transform-drug-risk-management-2/2025-12-17T19:54:17+00:00https://condrug.com/zuranolone-for-depression-how-this-new-gabaa-modulator-differs-from-traditional-antidepressants/2025-12-17T19:57:37+00:00https://condrug.com/ensifentrine-for-copd-dual-pde3-4-inhibitor-mechanism-benefits-clinical-data/2025-12-17T20:00:54+00:00https://condrug.com/what-is-retatrutide-triple-agonist-weight-loss-drug-explained-glp%e2%80%911-gip-glucagon-2/2025-12-17T20:00:55+00:00https://condrug.com/gefapixant-for-chronic-cough-how-this-p2x3-antagonist-is-changing-treatment/2025-12-17T20:02:40+00:00